UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:AP2A2-DRD4 |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: AP2A2-DRD4 | FusionPDB ID: 5225 | FusionGDB2.0 ID: 5225 | Hgene | Tgene | Gene symbol | AP2A2 | DRD4 | Gene ID | 161 | 1815 |
Gene name | adaptor related protein complex 2 subunit alpha 2 | dopamine receptor D4 | |
Synonyms | ADTAB|CLAPA2|HIP-9|HIP9|HYPJ | D4DR | |
Cytomap | 11p15.5 | 11p15.5 | |
Type of gene | protein-coding | protein-coding | |
Description | AP-2 complex subunit alpha-2100 kDa coated vesicle protein Cadapter-related protein complex 2 subunit alpha-2adaptin, alpha Badaptor related protein complex 2 alpha 2 subunitalpha-adaptin C; Huntingtin interacting protein Jalpha2-adaptinclathrin as | D(4) dopamine receptorD(2C) dopamine receptordopamine D4 receptorseven transmembrane helix receptor | |
Modification date | 20200313 | 20200329 | |
UniProtAcc | O94973 | . | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000332231, ENST00000448903, ENST00000534328, ENST00000525891, | ENST00000528733, ENST00000176183, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 13 X 10 X 12=1560 | 4 X 5 X 3=60 |
# samples | 22 | 7 | |
** MAII score | log2(22/1560*10)=-2.82597060022495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(7/60*10)=0.222392421336448 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: AP2A2 [Title/Abstract] AND DRD4 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | AP2A2(977224)-DRD4(639432), # samples:1 AP2A2(977224)-DRD4(640401), # samples:1 AP2A2(977224)-DRD4(639433), # samples:1 AP2A2(970311)-DRD4(640401), # samples:1 AP2A2(977223)-DRD4(639432), # samples:1 AP2A2(977223)-DRD4(640400), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | AP2A2-DRD4 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. AP2A2-DRD4 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. AP2A2-DRD4 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. AP2A2-DRD4 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | AP2A2 | GO:0072583 | clathrin-dependent endocytosis | 23676497 |
Tgene | DRD4 | GO:0000187 | activation of MAPK activity | 9843378|15755724 |
Tgene | DRD4 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway | 7512953|9003072|9843378 |
Tgene | DRD4 | GO:0007212 | dopamine receptor signaling pathway | 1840645 |
Tgene | DRD4 | GO:0032417 | positive regulation of sodium:proton antiporter activity | 7512953 |
Tgene | DRD4 | GO:0033674 | positive regulation of kinase activity | 15755724 |
Tgene | DRD4 | GO:0034776 | response to histamine | 16839358 |
Tgene | DRD4 | GO:0050482 | arachidonic acid secretion | 7512953 |
Tgene | DRD4 | GO:0050709 | negative regulation of protein secretion | 16839358 |
Tgene | DRD4 | GO:1901386 | negative regulation of voltage-gated calcium channel activity | 7921596 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | ACC | TCGA-OR-A5J7-01A | AP2A2 | chr11 | 977223 | + | DRD4 | chr11 | 639432 | + |
ChimerDB4 | ACC | TCGA-OR-A5J7-01A | AP2A2 | chr11 | 977223 | + | DRD4 | chr11 | 640400 | + |
ChimerDB4 | ACC | TCGA-OR-A5J7-01A | AP2A2 | chr11 | 977224 | + | DRD4 | chr11 | 639433 | + |
ChimerDB4 | ACC | TCGA-OR-A5J7-01A | AP2A2 | chr11 | 977224 | + | DRD4 | chr11 | 640401 | + |
ChimerDB4 | ACC | TCGA-OR-A5J7 | AP2A2 | chr11 | 977224 | + | DRD4 | chr11 | 639432 | + |
ChimerDB4 | UCEC | TCGA-EO-A3KW-01A | AP2A2 | chr11 | 970311 | + | DRD4 | chr11 | 640401 | + |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000534328 | AP2A2 | chr11 | 977224 | + | ENST00000176183 | DRD4 | chr11 | 639432 | + | 1823 | 745 | 142 | 1719 | 525 |
ENST00000332231 | AP2A2 | chr11 | 977224 | + | ENST00000176183 | DRD4 | chr11 | 639432 | + | 1822 | 744 | 141 | 1718 | 525 |
ENST00000448903 | AP2A2 | chr11 | 977224 | + | ENST00000176183 | DRD4 | chr11 | 639432 | + | 1822 | 744 | 141 | 1718 | 525 |
ENST00000534328 | AP2A2 | chr11 | 977224 | + | ENST00000176183 | DRD4 | chr11 | 639433 | + | 1823 | 745 | 142 | 1719 | 525 |
ENST00000332231 | AP2A2 | chr11 | 977224 | + | ENST00000176183 | DRD4 | chr11 | 639433 | + | 1822 | 744 | 141 | 1718 | 525 |
ENST00000448903 | AP2A2 | chr11 | 977224 | + | ENST00000176183 | DRD4 | chr11 | 639433 | + | 1822 | 744 | 141 | 1718 | 525 |
ENST00000534328 | AP2A2 | chr11 | 977223 | + | ENST00000176183 | DRD4 | chr11 | 639432 | + | 1823 | 745 | 142 | 1719 | 525 |
ENST00000332231 | AP2A2 | chr11 | 977223 | + | ENST00000176183 | DRD4 | chr11 | 639432 | + | 1822 | 744 | 141 | 1718 | 525 |
ENST00000448903 | AP2A2 | chr11 | 977223 | + | ENST00000176183 | DRD4 | chr11 | 639432 | + | 1822 | 744 | 141 | 1718 | 525 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000534328 | ENST00000176183 | AP2A2 | chr11 | 977224 | + | DRD4 | chr11 | 639432 | + | 0.041698437 | 0.9583016 |
ENST00000332231 | ENST00000176183 | AP2A2 | chr11 | 977224 | + | DRD4 | chr11 | 639432 | + | 0.041394025 | 0.95860595 |
ENST00000448903 | ENST00000176183 | AP2A2 | chr11 | 977224 | + | DRD4 | chr11 | 639432 | + | 0.041394025 | 0.95860595 |
ENST00000534328 | ENST00000176183 | AP2A2 | chr11 | 977224 | + | DRD4 | chr11 | 639433 | + | 0.041698437 | 0.9583016 |
ENST00000332231 | ENST00000176183 | AP2A2 | chr11 | 977224 | + | DRD4 | chr11 | 639433 | + | 0.041394025 | 0.95860595 |
ENST00000448903 | ENST00000176183 | AP2A2 | chr11 | 977224 | + | DRD4 | chr11 | 639433 | + | 0.041394025 | 0.95860595 |
ENST00000534328 | ENST00000176183 | AP2A2 | chr11 | 977223 | + | DRD4 | chr11 | 639432 | + | 0.041698437 | 0.9583016 |
ENST00000332231 | ENST00000176183 | AP2A2 | chr11 | 977223 | + | DRD4 | chr11 | 639432 | + | 0.041394025 | 0.95860595 |
ENST00000448903 | ENST00000176183 | AP2A2 | chr11 | 977223 | + | DRD4 | chr11 | 639432 | + | 0.041394025 | 0.95860595 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >5225_5225_1_AP2A2-DRD4_AP2A2_chr11_977223_ENST00000332231_DRD4_chr11_639432_ENST00000176183_length(amino acids)=525AA_BP=368 MPAVSKGDGMRGLAVFISDIRNCKSKEAEIKRINKELANIRSKFKGDKALDGYSKKKYVCKLLFIFLLGHDIDFGHMEAVNLLSSNRYTE KQIGYLFISVLVNSNSELIRLINNAIKNDLASRNPTFMGLALHCIASVGSREMAEAFAGEIPKVLVAGDTMDSVKQSAALCLLRLYRTSP DLVPMGDWTSRVVHLLNDQHLVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSA AVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLP QDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKA -------------------------------------------------------------- >5225_5225_2_AP2A2-DRD4_AP2A2_chr11_977223_ENST00000448903_DRD4_chr11_639432_ENST00000176183_length(amino acids)=525AA_BP=368 MPAVSKGDGMRGLAVFISDIRNCKSKEAEIKRINKELANIRSKFKGDKALDGYSKKKYVCKLLFIFLLGHDIDFGHMEAVNLLSSNRYTE KQIGYLFISVLVNSNSELIRLINNAIKNDLASRNPTFMGLALHCIASVGSREMAEAFAGEIPKVLVAGDTMDSVKQSAALCLLRLYRTSP DLVPMGDWTSRVVHLLNDQHLVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSA AVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLP QDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKA -------------------------------------------------------------- >5225_5225_3_AP2A2-DRD4_AP2A2_chr11_977223_ENST00000534328_DRD4_chr11_639432_ENST00000176183_length(amino acids)=525AA_BP=368 MPAVSKGDGMRGLAVFISDIRNCKSKEAEIKRINKELANIRSKFKGDKALDGYSKKKYVCKLLFIFLLGHDIDFGHMEAVNLLSSNRYTE KQIGYLFISVLVNSNSELIRLINNAIKNDLASRNPTFMGLALHCIASVGSREMAEAFAGEIPKVLVAGDTMDSVKQSAALCLLRLYRTSP DLVPMGDWTSRVVHLLNDQHLVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSA AVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLP QDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKA -------------------------------------------------------------- >5225_5225_4_AP2A2-DRD4_AP2A2_chr11_977224_ENST00000332231_DRD4_chr11_639432_ENST00000176183_length(amino acids)=525AA_BP=368 MPAVSKGDGMRGLAVFISDIRNCKSKEAEIKRINKELANIRSKFKGDKALDGYSKKKYVCKLLFIFLLGHDIDFGHMEAVNLLSSNRYTE KQIGYLFISVLVNSNSELIRLINNAIKNDLASRNPTFMGLALHCIASVGSREMAEAFAGEIPKVLVAGDTMDSVKQSAALCLLRLYRTSP DLVPMGDWTSRVVHLLNDQHLVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSA AVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLP QDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKA -------------------------------------------------------------- >5225_5225_5_AP2A2-DRD4_AP2A2_chr11_977224_ENST00000332231_DRD4_chr11_639433_ENST00000176183_length(amino acids)=525AA_BP=368 MPAVSKGDGMRGLAVFISDIRNCKSKEAEIKRINKELANIRSKFKGDKALDGYSKKKYVCKLLFIFLLGHDIDFGHMEAVNLLSSNRYTE KQIGYLFISVLVNSNSELIRLINNAIKNDLASRNPTFMGLALHCIASVGSREMAEAFAGEIPKVLVAGDTMDSVKQSAALCLLRLYRTSP DLVPMGDWTSRVVHLLNDQHLVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSA AVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLP QDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKA -------------------------------------------------------------- >5225_5225_6_AP2A2-DRD4_AP2A2_chr11_977224_ENST00000448903_DRD4_chr11_639432_ENST00000176183_length(amino acids)=525AA_BP=368 MPAVSKGDGMRGLAVFISDIRNCKSKEAEIKRINKELANIRSKFKGDKALDGYSKKKYVCKLLFIFLLGHDIDFGHMEAVNLLSSNRYTE KQIGYLFISVLVNSNSELIRLINNAIKNDLASRNPTFMGLALHCIASVGSREMAEAFAGEIPKVLVAGDTMDSVKQSAALCLLRLYRTSP DLVPMGDWTSRVVHLLNDQHLVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSA AVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLP QDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKA -------------------------------------------------------------- >5225_5225_7_AP2A2-DRD4_AP2A2_chr11_977224_ENST00000448903_DRD4_chr11_639433_ENST00000176183_length(amino acids)=525AA_BP=368 MPAVSKGDGMRGLAVFISDIRNCKSKEAEIKRINKELANIRSKFKGDKALDGYSKKKYVCKLLFIFLLGHDIDFGHMEAVNLLSSNRYTE KQIGYLFISVLVNSNSELIRLINNAIKNDLASRNPTFMGLALHCIASVGSREMAEAFAGEIPKVLVAGDTMDSVKQSAALCLLRLYRTSP DLVPMGDWTSRVVHLLNDQHLVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSA AVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLP QDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKA -------------------------------------------------------------- >5225_5225_8_AP2A2-DRD4_AP2A2_chr11_977224_ENST00000534328_DRD4_chr11_639432_ENST00000176183_length(amino acids)=525AA_BP=368 MPAVSKGDGMRGLAVFISDIRNCKSKEAEIKRINKELANIRSKFKGDKALDGYSKKKYVCKLLFIFLLGHDIDFGHMEAVNLLSSNRYTE KQIGYLFISVLVNSNSELIRLINNAIKNDLASRNPTFMGLALHCIASVGSREMAEAFAGEIPKVLVAGDTMDSVKQSAALCLLRLYRTSP DLVPMGDWTSRVVHLLNDQHLVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSA AVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLP QDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKA -------------------------------------------------------------- >5225_5225_9_AP2A2-DRD4_AP2A2_chr11_977224_ENST00000534328_DRD4_chr11_639433_ENST00000176183_length(amino acids)=525AA_BP=368 MPAVSKGDGMRGLAVFISDIRNCKSKEAEIKRINKELANIRSKFKGDKALDGYSKKKYVCKLLFIFLLGHDIDFGHMEAVNLLSSNRYTE KQIGYLFISVLVNSNSELIRLINNAIKNDLASRNPTFMGLALHCIASVGSREMAEAFAGEIPKVLVAGDTMDSVKQSAALCLLRLYRTSP DLVPMGDWTSRVVHLLNDQHLVQGGAWLLSPRLCDALMAMDVMLCTASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSA AVAAPVLCGLNDVRGRDPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSGPGPPSPTPPAPRLP QDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPGLPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKA -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr11:977224/chr11:639432) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
AP2A2 | . |
FUNCTION: Component of the adaptor protein complex 2 (AP-2). Adaptor protein complexes function in protein transport via transport vesicles in different membrane traffic pathways. Adaptor protein complexes are vesicle coat components and appear to be involved in cargo selection and vesicle formation. AP-2 is involved in clathrin-dependent endocytosis in which cargo proteins are incorporated into vesicles surrounded by clathrin (clathrin-coated vesicles, CCVs) which are destined for fusion with the early endosome. The clathrin lattice serves as a mechanical scaffold but is itself unable to bind directly to membrane components. Clathrin-associated adaptor protein (AP) complexes which can bind directly to both the clathrin lattice and to the lipid and protein components of membranes are considered to be the major clathrin adaptors contributing the CCV formation. AP-2 also serves as a cargo receptor to selectively sort the membrane proteins involved in receptor-mediated endocytosis. AP-2 seems to play a role in the recycling of synaptic vesicle membranes from the presynaptic surface. AP-2 recognizes Y-X-X-[FILMV] (Y-X-X-Phi) and [ED]-X-X-X-L-[LI] endocytosis signal motifs within the cytosolic tails of transmembrane cargo molecules. AP-2 may also play a role in maintaining normal post-endocytic trafficking through the ARF6-regulated, non-clathrin pathway. During long-term potentiation in hippocampal neurons, AP-2 is responsible for the endocytosis of ADAM10 (PubMed:23676497). The AP-2 alpha subunit binds polyphosphoinositide-containing lipids, positioning AP-2 on the membrane. The AP-2 alpha subunit acts via its C-terminal appendage domain as a scaffolding platform for endocytic accessory proteins. The AP-2 alpha and AP-2 sigma subunits are thought to contribute to the recognition of the [ED]-X-X-X-L-[LI] motif (By similarity). {ECO:0000250, ECO:0000269|PubMed:12960147, ECO:0000269|PubMed:14745134, ECO:0000269|PubMed:15473838, ECO:0000269|PubMed:19033387, ECO:0000269|PubMed:23676497}. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | AP2A2 | chr11:977223 | chr11:639432 | ENST00000332231 | + | 5 | 22 | 11_12 | 201.0 | 941.0 | Region | Phosphatidylinositol 3%2C4%2C5-trisphosphate binding |
Hgene | AP2A2 | chr11:977223 | chr11:639432 | ENST00000332231 | + | 5 | 22 | 57_61 | 201.0 | 941.0 | Region | Phosphatidylinositol 3%2C4%2C5-trisphosphate binding |
Hgene | AP2A2 | chr11:977223 | chr11:639432 | ENST00000332231 | + | 5 | 22 | 5_80 | 201.0 | 941.0 | Region | Note=Lipid-binding |
Hgene | AP2A2 | chr11:977223 | chr11:639432 | ENST00000448903 | + | 5 | 22 | 11_12 | 201.0 | 940.0 | Region | Phosphatidylinositol 3%2C4%2C5-trisphosphate binding |
Hgene | AP2A2 | chr11:977223 | chr11:639432 | ENST00000448903 | + | 5 | 22 | 57_61 | 201.0 | 940.0 | Region | Phosphatidylinositol 3%2C4%2C5-trisphosphate binding |
Hgene | AP2A2 | chr11:977223 | chr11:639432 | ENST00000448903 | + | 5 | 22 | 5_80 | 201.0 | 940.0 | Region | Note=Lipid-binding |
Hgene | AP2A2 | chr11:977224 | chr11:639432 | ENST00000332231 | + | 5 | 22 | 11_12 | 201.0 | 941.0 | Region | Phosphatidylinositol 3%2C4%2C5-trisphosphate binding |
Hgene | AP2A2 | chr11:977224 | chr11:639432 | ENST00000332231 | + | 5 | 22 | 57_61 | 201.0 | 941.0 | Region | Phosphatidylinositol 3%2C4%2C5-trisphosphate binding |
Hgene | AP2A2 | chr11:977224 | chr11:639432 | ENST00000332231 | + | 5 | 22 | 5_80 | 201.0 | 941.0 | Region | Note=Lipid-binding |
Hgene | AP2A2 | chr11:977224 | chr11:639432 | ENST00000448903 | + | 5 | 22 | 11_12 | 201.0 | 940.0 | Region | Phosphatidylinositol 3%2C4%2C5-trisphosphate binding |
Hgene | AP2A2 | chr11:977224 | chr11:639432 | ENST00000448903 | + | 5 | 22 | 57_61 | 201.0 | 940.0 | Region | Phosphatidylinositol 3%2C4%2C5-trisphosphate binding |
Hgene | AP2A2 | chr11:977224 | chr11:639432 | ENST00000448903 | + | 5 | 22 | 5_80 | 201.0 | 940.0 | Region | Note=Lipid-binding |
Hgene | AP2A2 | chr11:977224 | chr11:639433 | ENST00000332231 | + | 5 | 22 | 11_12 | 201.0 | 941.0 | Region | Phosphatidylinositol 3%2C4%2C5-trisphosphate binding |
Hgene | AP2A2 | chr11:977224 | chr11:639433 | ENST00000332231 | + | 5 | 22 | 57_61 | 201.0 | 941.0 | Region | Phosphatidylinositol 3%2C4%2C5-trisphosphate binding |
Hgene | AP2A2 | chr11:977224 | chr11:639433 | ENST00000332231 | + | 5 | 22 | 5_80 | 201.0 | 941.0 | Region | Note=Lipid-binding |
Hgene | AP2A2 | chr11:977224 | chr11:639433 | ENST00000448903 | + | 5 | 22 | 11_12 | 201.0 | 940.0 | Region | Phosphatidylinositol 3%2C4%2C5-trisphosphate binding |
Hgene | AP2A2 | chr11:977224 | chr11:639433 | ENST00000448903 | + | 5 | 22 | 57_61 | 201.0 | 940.0 | Region | Phosphatidylinositol 3%2C4%2C5-trisphosphate binding |
Hgene | AP2A2 | chr11:977224 | chr11:639433 | ENST00000448903 | + | 5 | 22 | 5_80 | 201.0 | 940.0 | Region | Note=Lipid-binding |
Tgene | DRD4 | chr11:977223 | chr11:639432 | ENST00000176183 | 0 | 4 | 249_312 | 95.0 | 420.0 | Region | Note=4 X 16 AA approximate tandem repeats of [PA]-A-P-G-L-P-[PQR]-[DG]-P-C-G-P-D-C-A-P | |
Tgene | DRD4 | chr11:977224 | chr11:639432 | ENST00000176183 | 0 | 4 | 249_312 | 95.0 | 420.0 | Region | Note=4 X 16 AA approximate tandem repeats of [PA]-A-P-G-L-P-[PQR]-[DG]-P-C-G-P-D-C-A-P | |
Tgene | DRD4 | chr11:977224 | chr11:639433 | ENST00000176183 | 0 | 4 | 249_312 | 95.0 | 420.0 | Region | Note=4 X 16 AA approximate tandem repeats of [PA]-A-P-G-L-P-[PQR]-[DG]-P-C-G-P-D-C-A-P | |
Tgene | DRD4 | chr11:977223 | chr11:639432 | ENST00000176183 | 0 | 4 | 249_264 | 95.0 | 420.0 | Repeat | Note=1%3B approximate | |
Tgene | DRD4 | chr11:977223 | chr11:639432 | ENST00000176183 | 0 | 4 | 265_280 | 95.0 | 420.0 | Repeat | Note=2 | |
Tgene | DRD4 | chr11:977223 | chr11:639432 | ENST00000176183 | 0 | 4 | 281_296 | 95.0 | 420.0 | Repeat | Note=3 | |
Tgene | DRD4 | chr11:977223 | chr11:639432 | ENST00000176183 | 0 | 4 | 297_312 | 95.0 | 420.0 | Repeat | Note=4%3B approximate | |
Tgene | DRD4 | chr11:977224 | chr11:639432 | ENST00000176183 | 0 | 4 | 249_264 | 95.0 | 420.0 | Repeat | Note=1%3B approximate | |
Tgene | DRD4 | chr11:977224 | chr11:639432 | ENST00000176183 | 0 | 4 | 265_280 | 95.0 | 420.0 | Repeat | Note=2 | |
Tgene | DRD4 | chr11:977224 | chr11:639432 | ENST00000176183 | 0 | 4 | 281_296 | 95.0 | 420.0 | Repeat | Note=3 | |
Tgene | DRD4 | chr11:977224 | chr11:639432 | ENST00000176183 | 0 | 4 | 297_312 | 95.0 | 420.0 | Repeat | Note=4%3B approximate | |
Tgene | DRD4 | chr11:977224 | chr11:639433 | ENST00000176183 | 0 | 4 | 249_264 | 95.0 | 420.0 | Repeat | Note=1%3B approximate | |
Tgene | DRD4 | chr11:977224 | chr11:639433 | ENST00000176183 | 0 | 4 | 265_280 | 95.0 | 420.0 | Repeat | Note=2 | |
Tgene | DRD4 | chr11:977224 | chr11:639433 | ENST00000176183 | 0 | 4 | 281_296 | 95.0 | 420.0 | Repeat | Note=3 | |
Tgene | DRD4 | chr11:977224 | chr11:639433 | ENST00000176183 | 0 | 4 | 297_312 | 95.0 | 420.0 | Repeat | Note=4%3B approximate | |
Tgene | DRD4 | chr11:977223 | chr11:639432 | ENST00000176183 | 0 | 4 | 132_152 | 95.0 | 420.0 | Topological domain | Cytoplasmic | |
Tgene | DRD4 | chr11:977223 | chr11:639432 | ENST00000176183 | 0 | 4 | 174_192 | 95.0 | 420.0 | Topological domain | Extracellular | |
Tgene | DRD4 | chr11:977223 | chr11:639432 | ENST00000176183 | 0 | 4 | 214_346 | 95.0 | 420.0 | Topological domain | Cytoplasmic | |
Tgene | DRD4 | chr11:977223 | chr11:639432 | ENST00000176183 | 0 | 4 | 368_382 | 95.0 | 420.0 | Topological domain | Extracellular | |
Tgene | DRD4 | chr11:977223 | chr11:639432 | ENST00000176183 | 0 | 4 | 404_419 | 95.0 | 420.0 | Topological domain | Cytoplasmic | |
Tgene | DRD4 | chr11:977223 | chr11:639432 | ENST00000176183 | 0 | 4 | 93_110 | 95.0 | 420.0 | Topological domain | Extracellular | |
Tgene | DRD4 | chr11:977224 | chr11:639432 | ENST00000176183 | 0 | 4 | 132_152 | 95.0 | 420.0 | Topological domain | Cytoplasmic | |
Tgene | DRD4 | chr11:977224 | chr11:639432 | ENST00000176183 | 0 | 4 | 174_192 | 95.0 | 420.0 | Topological domain | Extracellular | |
Tgene | DRD4 | chr11:977224 | chr11:639432 | ENST00000176183 | 0 | 4 | 214_346 | 95.0 | 420.0 | Topological domain | Cytoplasmic | |
Tgene | DRD4 | chr11:977224 | chr11:639432 | ENST00000176183 | 0 | 4 | 368_382 | 95.0 | 420.0 | Topological domain | Extracellular | |
Tgene | DRD4 | chr11:977224 | chr11:639432 | ENST00000176183 | 0 | 4 | 404_419 | 95.0 | 420.0 | Topological domain | Cytoplasmic | |
Tgene | DRD4 | chr11:977224 | chr11:639432 | ENST00000176183 | 0 | 4 | 93_110 | 95.0 | 420.0 | Topological domain | Extracellular | |
Tgene | DRD4 | chr11:977224 | chr11:639433 | ENST00000176183 | 0 | 4 | 132_152 | 95.0 | 420.0 | Topological domain | Cytoplasmic | |
Tgene | DRD4 | chr11:977224 | chr11:639433 | ENST00000176183 | 0 | 4 | 174_192 | 95.0 | 420.0 | Topological domain | Extracellular | |
Tgene | DRD4 | chr11:977224 | chr11:639433 | ENST00000176183 | 0 | 4 | 214_346 | 95.0 | 420.0 | Topological domain | Cytoplasmic | |
Tgene | DRD4 | chr11:977224 | chr11:639433 | ENST00000176183 | 0 | 4 | 368_382 | 95.0 | 420.0 | Topological domain | Extracellular | |
Tgene | DRD4 | chr11:977224 | chr11:639433 | ENST00000176183 | 0 | 4 | 404_419 | 95.0 | 420.0 | Topological domain | Cytoplasmic | |
Tgene | DRD4 | chr11:977224 | chr11:639433 | ENST00000176183 | 0 | 4 | 93_110 | 95.0 | 420.0 | Topological domain | Extracellular | |
Tgene | DRD4 | chr11:977223 | chr11:639432 | ENST00000176183 | 0 | 4 | 111_131 | 95.0 | 420.0 | Transmembrane | Helical%3B Name%3D3 | |
Tgene | DRD4 | chr11:977223 | chr11:639432 | ENST00000176183 | 0 | 4 | 153_173 | 95.0 | 420.0 | Transmembrane | Helical%3B Name%3D4 | |
Tgene | DRD4 | chr11:977223 | chr11:639432 | ENST00000176183 | 0 | 4 | 193_213 | 95.0 | 420.0 | Transmembrane | Helical%3B Name%3D5 | |
Tgene | DRD4 | chr11:977223 | chr11:639432 | ENST00000176183 | 0 | 4 | 347_367 | 95.0 | 420.0 | Transmembrane | Helical%3B Name%3D6 | |
Tgene | DRD4 | chr11:977223 | chr11:639432 | ENST00000176183 | 0 | 4 | 383_403 | 95.0 | 420.0 | Transmembrane | Helical%3B Name%3D7 | |
Tgene | DRD4 | chr11:977224 | chr11:639432 | ENST00000176183 | 0 | 4 | 111_131 | 95.0 | 420.0 | Transmembrane | Helical%3B Name%3D3 | |
Tgene | DRD4 | chr11:977224 | chr11:639432 | ENST00000176183 | 0 | 4 | 153_173 | 95.0 | 420.0 | Transmembrane | Helical%3B Name%3D4 | |
Tgene | DRD4 | chr11:977224 | chr11:639432 | ENST00000176183 | 0 | 4 | 193_213 | 95.0 | 420.0 | Transmembrane | Helical%3B Name%3D5 | |
Tgene | DRD4 | chr11:977224 | chr11:639432 | ENST00000176183 | 0 | 4 | 347_367 | 95.0 | 420.0 | Transmembrane | Helical%3B Name%3D6 | |
Tgene | DRD4 | chr11:977224 | chr11:639432 | ENST00000176183 | 0 | 4 | 383_403 | 95.0 | 420.0 | Transmembrane | Helical%3B Name%3D7 | |
Tgene | DRD4 | chr11:977224 | chr11:639433 | ENST00000176183 | 0 | 4 | 111_131 | 95.0 | 420.0 | Transmembrane | Helical%3B Name%3D3 | |
Tgene | DRD4 | chr11:977224 | chr11:639433 | ENST00000176183 | 0 | 4 | 153_173 | 95.0 | 420.0 | Transmembrane | Helical%3B Name%3D4 | |
Tgene | DRD4 | chr11:977224 | chr11:639433 | ENST00000176183 | 0 | 4 | 193_213 | 95.0 | 420.0 | Transmembrane | Helical%3B Name%3D5 | |
Tgene | DRD4 | chr11:977224 | chr11:639433 | ENST00000176183 | 0 | 4 | 347_367 | 95.0 | 420.0 | Transmembrane | Helical%3B Name%3D6 | |
Tgene | DRD4 | chr11:977224 | chr11:639433 | ENST00000176183 | 0 | 4 | 383_403 | 95.0 | 420.0 | Transmembrane | Helical%3B Name%3D7 |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | DRD4 | chr11:977223 | chr11:639432 | ENST00000176183 | 0 | 4 | 1_29 | 95.0 | 420.0 | Topological domain | Extracellular | |
Tgene | DRD4 | chr11:977223 | chr11:639432 | ENST00000176183 | 0 | 4 | 51_71 | 95.0 | 420.0 | Topological domain | Cytoplasmic | |
Tgene | DRD4 | chr11:977224 | chr11:639432 | ENST00000176183 | 0 | 4 | 1_29 | 95.0 | 420.0 | Topological domain | Extracellular | |
Tgene | DRD4 | chr11:977224 | chr11:639432 | ENST00000176183 | 0 | 4 | 51_71 | 95.0 | 420.0 | Topological domain | Cytoplasmic | |
Tgene | DRD4 | chr11:977224 | chr11:639433 | ENST00000176183 | 0 | 4 | 1_29 | 95.0 | 420.0 | Topological domain | Extracellular | |
Tgene | DRD4 | chr11:977224 | chr11:639433 | ENST00000176183 | 0 | 4 | 51_71 | 95.0 | 420.0 | Topological domain | Cytoplasmic | |
Tgene | DRD4 | chr11:977223 | chr11:639432 | ENST00000176183 | 0 | 4 | 30_50 | 95.0 | 420.0 | Transmembrane | Helical%3B Name%3D1 | |
Tgene | DRD4 | chr11:977223 | chr11:639432 | ENST00000176183 | 0 | 4 | 72_92 | 95.0 | 420.0 | Transmembrane | Helical%3B Name%3D2 | |
Tgene | DRD4 | chr11:977224 | chr11:639432 | ENST00000176183 | 0 | 4 | 30_50 | 95.0 | 420.0 | Transmembrane | Helical%3B Name%3D1 | |
Tgene | DRD4 | chr11:977224 | chr11:639432 | ENST00000176183 | 0 | 4 | 72_92 | 95.0 | 420.0 | Transmembrane | Helical%3B Name%3D2 | |
Tgene | DRD4 | chr11:977224 | chr11:639433 | ENST00000176183 | 0 | 4 | 30_50 | 95.0 | 420.0 | Transmembrane | Helical%3B Name%3D1 | |
Tgene | DRD4 | chr11:977224 | chr11:639433 | ENST00000176183 | 0 | 4 | 72_92 | 95.0 | 420.0 | Transmembrane | Helical%3B Name%3D2 |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
![]() |
Gene | STRING network |
AP2A2 | |
DRD4 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to AP2A2-DRD4 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to AP2A2-DRD4 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |